🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-centre, open-label, dose escalation, Phase 1 study. The pr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-12
Trial ID
NCT03738111
Treatments Being Tested
The purpose of this study is to determine safety and anti-tumor immune acti...
Status
Terminated
Location
Royal Brisbane & Women's Hospital (RBWH)
Start Date
2016-09
Trial ID
NCT02933944
Treatments Being Tested
This is a multi-center, open-label, dose escalation study....
Status
Completed
Location
GRU
Start Date
2012-09
Trial ID
NCT01699152
Treatments Being Tested
This is a multicenter, open-label, dose escalation Phase 1 study....
Status
Completed
Location
RMCC
Start Date
2010-08
Trial ID
NCT01204164
Treatments Being Tested
The aim of the study was to explore the dose-limiting toxicity (DLT) and th...
Status
Unknown
Location
Sun Yat-Sen University Cancer Center
Start Date
2019-03-22
Trial ID
NCT03904628
This is a three parallel cohort, open-labeled, non-randomized, multicenter ...
Status
Completed
Location
Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH uniklinieken
Start Date
2018-06-12
Trial ID
NCT03224104
Treatments Being Tested
Background: Zotiraciclib (TG02) is an investigational drug that penetrates...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2016-12-14
Trial ID
NCT02942264
Treatments Being Tested